Clinical trial
GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
NCT00443235 · PETHEMA Foundation, Other · Completed
Key facts
| NCT number | NCT00443235 |
|---|---|
| Title | GEM05 for Patients With Multiple Myeloma More Than 65 Years Old |
| Official title | A National, Open-Label, Multicenter, Randomized, Comparative Phase III Study of Induction Treatment With Melphalan/Prednisone/Velcade Versus Thalidomide / Prednisone / Velcade and Maintenance Treatment With Thalidomide / Velcade Versus Prednisone / Velcade in Untreated Patients With Multiple Myeloma… |
| Lead sponsor | PETHEMA Foundation, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Melphalan/Prednisone/Velcade, Thalidomide/Prednisone/Velcade |
| Enrollment | 260 |
| Start date | Mar 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Dec 1, 2009 |
| First posted | Mar 5, 2007 |
| Last update posted | Sep 19, 2011 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: